BlackRock tops 5% stake in Abivax, disclosure shows
ABVX•BlackRock crossed above the 5% threshold in Abivax on Sept. 25, holding 5.14% of its capital and voting rights of 5.07%, equal to 4,487,762 shares.
1. Stake disclosure
BlackRock’s stake in Abivax rose above 5% on Sept. 25, reaching 5.14% of capital. Its voting rights stake rose to 5.07%, or 4,487,762 shares; the move reflected an increase in shares held as collateral.
